US Stem Cell Inc (USRM)

[Gaintrader]

"A solid team and business plan has led to this strong start to 2014," said Mike Tomas, President and Chief Executive Officer of Bioheart. "We have already made great progress and are poised for continued momentum."

Whether shares were purchased or issued to extinguish large amounts of outstanding debt, at a gain, is like splitting invisible hairs on the bottom line of BHRT's obviously improving balance sheet. Seems to be a completely immaterial difference at this point, IMO.